Methods and software tools for design evaluation in population pharmacokinetics–pharmacodynamics studies
Joakim Nyberg(Uppsala University), France Mentré(Université Claude Bernard Lyon 1), Kayode Ogungbenro(University of Manchester), Caroline Bazzoli(Laboratoire Jean Kuntzmann), Sergei Leonov(AstraZeneca (United States)), Stephen B. Duffull(The University of Queensland), Alexander Aliev(Russian Academy of Sciences), Andrew C. Hooker(Uppsala University)
Cited by 82
Related Papers
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|The Lancet Infectious Diseases|2021|344
Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques
|Stroke|2014|197
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy
|The Annual Review of Pharmacology and Toxicology|2020|179
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
|The Lancet Respiratory Medicine|2023|124